{
    "2021-06-22": [
        [
            {
                "time": "",
                "original_text": "医药生物行业双周报",
                "features": {
                    "keywords": [
                        "医药",
                        "生物",
                        "双周报"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "张坤“踩雷”教育股！董承非、谢治宇等多个产品排名垫底",
                "features": {
                    "keywords": [
                        "张坤",
                        "踩雷",
                        "教育股",
                        "董承非",
                        "谢治宇"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "教育"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "医药行业2021年半年报业绩前瞻：CXO、生物制品、创新器械、医疗服务有望持续高增长",
                "features": {
                    "keywords": [
                        "医药",
                        "2021",
                        "半年报",
                        "CXO",
                        "生物制品",
                        "创新器械",
                        "医疗服务",
                        "高增长"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "CXO",
                        "生物制品",
                        "创新器械",
                        "医疗服务"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            }
        ]
    ]
}